Econix

What Econix does

Econix is a private healthcare consulting and research services firm that advises pharmaceutical, medical device, and biotechnology companies, governmental organizations, NGOs, academic institutions, UN agencies, and funding bodies on market access, health economics and outcomes research (HEOR), pricing and reimbursement, value dossier preparation, and health policy. The firm positions itself as "architects of strategic healthcare solutions" focused on developing health markets across Eastern Europe, Western Asia, North Africa, the Middle East, and North America, with operating presence in Estonia (Tallinn HQ), Türkiye (Samsun R&D and operating entity), Tunisia, and the USA.

The company's core deliverable is bespoke professional services—not a software or platform product—organized around engagements such as Executive Training, Product Positioning Strategy, Market Access Processes Analysis, KOL & Payer Research, Pricing Scenarios & Sequence, and Value Dossier Preparation, with specialty support for orphan drug strategies. The ECONiX Academy sub-brand layers three structured training courses (HEOR & Market Access, Market Access in Emerging Markets, Market Access in Developed Markets) over the consulting base. Output is evidenced by 200+ projects, 25+ articles, 85+ posters, 35+ reports, 15+ courses delivered, and 20+ seminars. No proprietary technology, API, SDK, or app product is offered.

Econix operates on a quote-based, project-by-project consulting model with multi-year contract cadences, reached through direct sales and business development rather than inbound or channel-led marketing. Revenue is professional services fees only. The Estonian entity (ECONiX Research OÜ) and the Turkish operating entity (ECONiX Analiz Araştırma ve Danışmanlık A.Ş.) are both registered, and the firm maintains compliance with KVKK, the UK Bribery Act, the OECD Anti-Bribery Convention, and EU PIF Directive—enabling its pursuit of government and multilateral contracts. Estimated headcount is 1–10, and the firm has received a "Strongest in Estonia" recognition from AS Creditinfo Eesti.

Name

Econix

Legal name

ECONiX Analiz Araştırma ve Danışmanlık A.Ş.

Website

http://www.econix.net/

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Econix is a private healthcare consulting and research firm advising pharmaceutical, medical device, and biotech companies, governments, NGOs, UN agencies, and academic institutions on market access, HEOR, pricing and reimbursement, and value dossiers across emerging and developing health markets in Eastern Europe, Western Asia, North Africa, the Middle East, and North America.

Ownership category

akta.pro rank

Headquarters

HQ city

Istanbul

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Strategic Consulting Services: ECONiX generates revenue through professional consulting engagements including market access strategy, pricing analysis, KOL & payer research, value dossier preparation, and regulatory compliance consulting. Services are tailored to pharmaceutical companies, governmental organizations, and healthcare institutions.
2. Executive Training Programs: The company offers training programs including HEOR & Market Access courses, Market Access in Emerging Markets, and Market Access in Developed Markets. These training services provide capacity building for professionals from government, academia, and industry.
3. Research and Publication Services: ECONiX provides research services resulting in publications, posters, and reports. The company maintains a publishing operation registered with the Estonian National Library.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Econix provides strategic healthcare consulting services to pharmaceutical, medical device, and biotechnology companies, governmental organizations, NGOs, and academic institutions. The company delivers market access strategy, health economics and outcomes research (HEOR), pricing and reimbursement analysis, value dossier preparation, KOL & payer research, and executive training programs through its ECONiX Academy sub-brand.

Product overview

Econix is a healthcare consulting and research company operating as a unified service offering rather than a software platform. The portfolio consists of strategic consulting services complemented by the ECONiX Academy educational sub-brand. Core consulting services include Executive Training, Product Positioning Strategy, Market Access Processes Analysis, KOL & Payer Research, Pricing Scenarios & Sequence, and Value Dossier Preparation. The ECONiX Academy offers three distinct courses: HEOR & Market Access Course (foundational training in health economics), Market Access in Emerging Markets Course (covering Eastern Europe, North Africa, Middle East, and Asia), and Market Access in Developed Markets Course (covering Europe and North America). Additional specialized services address pharmaceutical companies' needs for orphan drug strategies including EMA designation management.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategic Healthcare Consulting Services Comprehensive consulting services for pharmaceutical, medical device, and biotechnology companies, governmental organizations, consulting firms, NGOs, academic institutions, research organizations, UN agencies, and funding bodies, focusing on market access, health economics & outcomes research, policy, medical affairs, and business development.
• Executive Training Customized executive training covering pricing, patient sales, real-world evidence, private health insurance, and healthcare systems across Türkiye, North Africa, Middle East, Eastern Europe, and Western Asia, with emphasis on early access programs.
• Product Positioning Strategy Strategic service including product profile review, competitive environment analysis, market dynamics assessment, pricing and reimbursement analysis of competitors, and target population identification.
• Market Access Processes Analysis Analysis of country-specific pricing and reimbursement processes, HTA reviews, mapping of market access requirements, and identification of critical success factors for market entry.
• KOL & Payer Research Research services including interview guide development, key opinion leader and payer interviews, and analysis and consolidation of findings for strategic decision-making.
• Pricing Scenarios & Sequence Assessment of achievable and optimal pricing per country, development of possible scenarios, launch sequence planning, and analysis of international and national price referencing.
• Value Dossier Preparation Comprehensive value dossier preparation including systematic literature research, meta-analysis, modeling, cost-effectiveness and cost-utility analysis, and budget impact analysis.
• Orphan Drug Strategies Specialized strategies for orphan drugs considering unique market dynamics, including management of Orphan Designation process under EMA.
• HEOR & Market Access Course A foundational course providing information about health economics and outcome research for participants from government, academy, and industry, covering introduction to health economics, calculation of health utilization, modeling basics, and market access overview.
• Market Access in Emerging Markets Course A comprehensive training program covering pharmaceutical regulatory processes, reimbursement systems, and tender-focused market entry strategies for generic and biosimilar products in emerging markets including Eastern Europe, North Africa, Middle East, and Asia.
• Market Access in Developed Markets Course Training program providing information for pharmaceutical companies about regulatory needs for EMA and country-based pharmaceuticals in Europe, HTA overview, pricing and reimbursement schemes, as well as FDA regulatory requirements and North American market access.

Quantifiable outcome

• 200+ successful projects completed across healthcare markets
• +1 more outcomes

Segments9 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Alira Health: Mid-sized healthcare and life sciences consulting firm offering market access, HEOR, and clinical/regulatory services. Comparable as a smaller, growth-stage peer with overlapping emerging-markets pharma advisory offerings.

Direct peers

• Evidera (Thermo Fisher Scientific): Dedicated HEOR, market access, and real-world evidence consultancy serving pharma and biotech. Highly comparable on the value-dossier, HTA, and pricing engagements that constitute core Econix service lines.
• ZS Associates: Global consulting firm focused on pharma and biotech, with strong market access, pricing, and HEOR practices. Directly comparable because it competes for the same pharma market access and pricing strategy mandates ECONiX pursues, especially for emerging-markets launches.
• BresMed Health Solutions: Specialist HEOR and market access consultancy serving pharma and medtech clients globally. Directly comparable on HEOR modeling, value dossier, and HTA submission services, and of similar specialist-firm profile to Econix.
• Charles River Associates: Consulting firm with a Life Sciences practice offering HEOR, market access, and pricing/reimbursement services to pharma. Directly comparable on service mix (HEOR and value dossiers) and pharma buyer base, though with a significantly larger global footprint.
• PRMA Consulting: Specialist market access and pricing consultancy serving global pharma. Directly comparable as a focused competitor in value-dossier preparation and payer engagement strategies for pharma launches.
• Simon-Kucher & Partners (Life Sciences): Global consulting firm with a dedicated Life Sciences practice focused on pricing, market access, and commercialization. Directly comparable on the pricing-strategy and launch-sequence services Econix offers to pharma clients.

Broad incumbents

• Syneos Health: Contract research and commercial services provider serving pharma, with market access and consulting capabilities. Comparable as a broader pharma services incumbent that competes for some of the same market access and commercialization mandates.
• McKinsey & Company (Pharmaceuticals & Medical Products Practice): Global management consultancy with a major pharma and medical products practice covering market access, pricing, and policy. Overlaps with Econix's strategic consulting scope but operates at vastly larger scale and with broader scope.
• IQVIA: Global leader in healthcare data, analytics, and consulting with deep HEOR and market access practices. Comparable because it sells the same pharma market access and value-dossier services ECONiX offers, but at vastly larger scale across developed and emerging markets.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/econix

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Econix